Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of rivaroxaban for the prevention of deep vein thrombosis in patients with left iliac vein compression treated with stent implantation.


Clinical Trial Description

Left Iliac Vein Compression Syndrome (LIVCS) is a disease of iliac vein stenosis/occlusion caused by chronic friction and compression of the left iliac vein by the right common iliac artery and lumbar vertebra. It is also called Cockett syndrome or May-Thurner syndrome. Recently, left iliac vein balloon dilatation with stent implantation have been used to treat patients with LIVCS, and have achieved good results. However, no matter the iliac vein stenosis or occlusion, interventional therapy can directly cause local trauma and intimal injury, which is a clear inducement of local thrombosis. Therefore, high intensity anticoagulation therapy is still needed to prevent secondary thrombosis in stent after left iliac vein balloon dilatation with stent implantation. At present, the postoperative anticoagulation regimen of these patients is early heparin anticoagulant therapy, and later warfarin anticoagulant therapy. However, due to the narrow therapeutic window of the drug, patients need to adjust the dosage according to coagulation function under the guidance of doctors. Rivaroxaban can simplify treatment, and is safe. Previous studies have shown that rivaroxaban is effective in preventing deep venous thrombosis after orthopaedic surgery. Rivaroxaban has also been shown to be safe and effective in anticoagulation therapy for patients with deep venous thrombosis and pulmonary embolism. However, Rivaroxaban lacks sufficient clinical data for adjuvant anticoagulation therapy after balloon dilatation with stent implantation. Therefore, this study should be carried out to provide the basis for LIVCS treatment guidelines and explore the clinical indications of rivaroxaban. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04067505
Study type Interventional
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Li Yin
Phone 86-0571-87913706
Email lawson4001@zju.edu.cn
Status Recruiting
Phase Phase 3
Start date May 18, 2020
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT05076448 - The Efficacy and Safety of Interventions on the Pelvic Veins in Pelvic Venous Disorders
Not yet recruiting NCT03262987 - Color Doppler U/S vs MSCT Venography in May-Thurner Syndrome N/A
Active, not recruiting NCT04580160 - Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System N/A
Recruiting NCT05628948 - Vascular Lab Resource (VLR) Biorepository
Completed NCT06180122 - The Use and Reproducibility of Duplex Ultrasound to Provide Indices of Left Common Iliac Vein Diameter N/A
Completed NCT02655887 - BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease N/A
Recruiting NCT02584374 - Balloon Test for Iliac Vein Compression N/A
Recruiting NCT02240914 - Vascular Ultrasound Versus Intravascular Ultrasound for Diagnosing Iliac Vein Obstruction N/A
Completed NCT02149212 - Iliac Vein Stenting in Advanced Chronic Venous Insufficiency Phase 4
Completed NCT01846780 - Treadmill Pilot Study (Invasive Pressure Measurements in PTS) N/A
Not yet recruiting NCT05409781 - Prevalence of May-Thurner Syndrome in 1st-degree Relatives of Symptomatic Patients
Completed NCT01206751 - Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation N/A